Just In
- 32 min ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 50 min ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
- 2 hrs ago Monthly Love Horoscope For May 2024: Virgo Needs To Make Their Partner Feel Secure In Relationships
- 3 hrs ago When Will Vaishakh Month 2024 Start? Vrats And Festivals That Will Fall This Month, Complete List!
Don't Miss
- Technology Infinix Note 40 Pro Plus 5G Goes on Sale in India Today via Flipkart: Check Price, Specs, Offers
- Sports IPL 2024: Why Virat Kohli decided to stay at RCB despite offers from other Teams?
- Finance Strong Listing: Vodafone Idea FPO Soars In Debut, Shares Rebound; KM Birla Lauds Success
- News Bha: New Shoe Sizing System To Replace US/UK Sizes: What It Is And Why It Matters For India
- Movies Ranneeti: Balakot & Beyond Full Series LEAKED In HD For Free Download After Its Release; DEETS -
- Automobiles India's Aviation Authority Mandates Children Under 13 To Sit With Parents On Flights
- Education JEE Main Result 2024 Out, Telangana's 15 Toppers Shine, Check Statewise List of 56 Candidates with Perfect 100
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Omicron May Not Evade All Monoclonal Antibodies, Lab Study Suggests
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens such as viruses.
Several past studies have shown that such antibodies are unsuccessful in neutralising Omicron.
The team led by researchers at Washington University, US, tested five antibody combinations, including those discovered at Vanderbilt University Medical Centre (VUMC) in the US.
The study, recently published in the journal Nature Medicine, found that antibodies, including those in clinical use by biopharmaceutical companies Celltrion, Regeneron and Eli Lilly, completely lost the ability to neutralise Omicron in cell culture.
The antibodies developed at VUMC had a reduced neutralising ability, while as an antibody developed by Vir Biotechnology, US, was minimally affected, the researchers found.
"Omicron escapes recognition by several of the monoclonal antibodies that are being used for therapy," said James Crowe director of the Vanderbilt Vaccine Center, whose team discovered the monoclonal antibodies at VUMC which were later optimised by AstraZeneca into an antibody combination called Evusheld.
"The precursor antibody of Vir Biotechnology's sotrovimab, and the prophylaxis antibodies in Evusheld retain substantial though reduced activity," said Crowe, coauthor of the research paper.
Although these data suggest that some monoclonal antibodies in clinical use might retain the benefit, more experiments are needed to support this conclusion and inform clinical decisions, the authors noted.
The loss of neutralising ability in Omicron is due to the more than 30 mutations in its "spike" protein, the antibody target on the surface of the virus which helps it to enter and infect cells.
The loss of inhibitory activity in the study is consistent with the observation that antibody responses generated after vaccination or natural infection also lose substantial inhibitory activity against Omicron, the researchers said.
That finding may explain in part the rise in symptomatic infections caused by the Omicron variant in people who have previously been vaccinated, they said.
The study "is good news, since we still have a least one antibody-drug we can use for each of the indications, prevention or therapy," Crowe added.
The continued identification and use of broadly and potently neutralising monoclonal antibodies that target the most highly conserved and least likely to mutate portions of the spike protein are needed to protect against Omicron and future variants, the researchers added.
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthDo You Pick Your Nose? Stop! It Can Increase COVID Risk
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthVitamin D Deficiency Linked With Increased Risk Of Long COVID
- healthCOVID Surge In India: Do You Need A COVID-19 Booster Shot?
- healthCOVID-19: IMA Cites 3 Reasons Behind Recent Surge In Covid-19 Cases: What Are They?